Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Dec-23 5:35 PM View:  | Margolin Yael Director | Point Biopharma Global Inc. (RACA) | 27-Dec-23 | Disposition | 1,710 | -- | -- | (100%) 1.71K to 0 | |
| 27-Dec-23 5:37 PM View: | Lubner David Charles Director | Point Biopharma Global Inc. (RACA) | 27-Dec-23 | Disposition | 3,600 | -- | -- | (100%) 3.6K to 0 | |
| 27-Dec-23 5:37 PM View: | Malik Rajesh Director | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 3,700 | -- | -- | (100%) 3.7K to 0 | |
| 27-Dec-23 5:37 PM View: | Hogue Gerald L. Director | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 21,596 | -- | -- | (100%) 21.6K to 0 | |
| 27-Dec-23 5:37 PM View: | Lubner David Charles Director | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 35,400 | -- | -- | (91%) 39.0K to 3.6K | |
| 27-Dec-23 5:41 PM View: | Goodman Jonathan R. Director | Point Biopharma Global Inc. (RACA) | 26-Dec-23 | Disposition (change in control) | 41,872 | -- | -- | (100%) 41.87K to 0 | |
| 27-Dec-23 5:35 PM View: | Silber Allan C Executive Chairman Director | Point Biopharma Global Inc. (RACA) | 22-Dec-23 | Disposition (change in control) | 8,727,980 | -- | -- | (100%) 8.73M to 0 | |
| 27-Dec-23 5:40 PM View: | McCann Joe A. Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 22-Dec-23 | Disposition (change in control) | 2,160 | -- | -- | (< 1%) 3.5M to 3.49M | |
| 27-Dec-23 5:39 PM View: | Fleshner Neil E. Chief Medical Officer Director | Point Biopharma Global Inc. (RACA) | 22-Dec-23 | Disposition (change in control) | 2,773,040 | -- | -- | (92%) 3.01M to 233.53K | |
| 27-Dec-23 5:40 PM View: | McCann Joe A. Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 22-Dec-23 | Disposition (change in control) | 3,494,150 | -- | -- | (100%) 3.49M to 0 | |
| 27-Dec-23 5:39 PM View: | Fleshner Neil E. Chief Medical Officer Director | Point Biopharma Global Inc. (RACA) | 22-Dec-23 | Disposition (change in control) | 233,529 | -- | -- | (100%) 233.53K to 0 | |
| 20-Dec-23 6:09 PM View: | Bvf Partners L P/il | Point Biopharma Global Inc. (RACA) | 18-Dec-23 | Private Sale | 17,161,300 | $12.45 | $213,658,000.00 | (100%) 17.16M to 0 | |
| 07-Nov-23 6:33 PM View: | McCann Joe A. Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 06-Nov-23 | Gift | 120,000 | -- | -- | (3%) 3.62M to 3.5M | |
| 07-Nov-23 6:31 PM View: | Silber Allan C Executive Chairman Director | Point Biopharma Global Inc. (RACA) | 03-Nov-23 | Gift | 500,000 | -- | -- | (5%) 9.23M to 8.73M | |
| 02-Nov-23 6:30 PM View: | Fleshner Neil E. Chief Medical Officer Director | Point Biopharma Global Inc. (RACA) | 31-Oct-23 | Gift | 250,000 | -- | -- | (8%) 3.26M to 3.01M | |
| 23-Mar-23 8:09 PM View: | Hogue Gerald L. Director | Point Biopharma Global Inc. (RACA) | 21-Mar-23 | Option Exercise | 17,936 | $6.97 | $125,014.00 | 490% 3.66K to 21.6K | |
| 30-Nov-22 7:56 PM View: | McCann Joe A. Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 29-Nov-22 | Private Purchase | 2,160 | $6.64 | $14,342.40 | < 1% 3.61M to 3.62M | |
| 28-Nov-22 4:01 PM View: | Malik Rajesh Director | Point Biopharma Global Inc. (RACA) | 28-Nov-22 | Private Purchase | 3,700 | $6.66 | $24,642.00 | 100% 0 to 3.7K | |
| 28-Nov-22 4:02 PM View: | Hogue Gerald L. Director | Point Biopharma Global Inc. (RACA) | 25-Nov-22 | Private Purchase | 3,660 | $6.82 | $24,942.90 | 100% 0 to 3.66K | |
| 28-Nov-22 4:03 PM View: | Lubner David Charles Director | Point Biopharma Global Inc. (RACA) | 23-Nov-22 | Private Purchase | 3,600 | $6.85 | $24,660.00 | 100% 0 to 3.6K | |
| 23-Nov-22 12:43 PM View: | Margolin Yael Director | Point Biopharma Global Inc. (RACA) | 21-Nov-22 | Private Purchase | 1,710 | $6.56 | $11,217.60 | 100% 0 to 1.71K | |
| 21-Nov-22 5:54 PM View: | Goodman Jonathan R. Director | Point Biopharma Global Inc. (RACA) | 18-Nov-22 | Private Purchase | 6,000 | $6.33 | $37,980.00 | 17% 35.87K to 41.87K | |
| 21-Nov-22 5:52 PM View: | Silber Allan C Executive Chairman Director 10% Owner | Point Biopharma Global Inc. (RACA) | 18-Nov-22 | Purchase | 22,397 | $6.50 | $145,580.00 | < 1% 9.21M to 9.23M | |
| 21-Nov-22 5:52 PM View: | Silber Allan C Executive Chairman Director 10% Owner | Point Biopharma Global Inc. (RACA) | 17-Nov-22 | Private Purchase | 27,603 | $6.00 | $165,618.00 | < 1% 9.18M to 9.21M | |
| 26-May-22 4:05 PM View: | Fleshner Neil E. Chief Medical Officer Director | Point Biopharma Global Inc. (RACA) | 25-May-22 | Sale | 564,204 | $7.51 | $4,237,170.00 | (15%) 3.82M to 3.26M | |
| 30-Jun-21 9:30 PM View: | McCann Joe A. Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 3,614,150 | -- | -- | 100% 0 to 3.61M | |
| 30-Jun-21 10:00 PM View: | Gottlieb Michael M. Chief Commercial Officer | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 1,156,890 | -- | -- | 100% 0 to 1.16M | |
| 30-Jun-21 9:31 PM View: | Silber Allan C Director 10% Owner | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 4,218,600 | -- | -- | 100% 0 to 4.22M | |
| 30-Jun-21 10:00 PM View: | Goodman Jonathan R. Director | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 21,523 | -- | -- | 100% 0 to 21.52K | |
| 14-Feb-22 10:00 PM View: | Silber Allan C Director 10% Owner | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 313,884 | -- | -- | 4% 8.86M to 9.18M | |
| 30-Jun-21 9:31 PM View: | Silber Allan C Director 10% Owner | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 4,645,490 | -- | -- | 110% 4.22M to 8.86M | |
| 30-Jun-21 10:00 PM View: | Goodman Jonathan R. Director | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Grant | 35,872 | -- | -- | 167% 21.52K to 57.4K | |
| 14-Feb-22 10:00 PM View: | Silber Allan C Director 10% Owner | Point Biopharma Global Inc. (RACA) | 30-Jun-21 | Disposition (other) | 23,309 | -- | -- | (< 1%) 9.18M to 9.15M | |
| 30-Jun-21 4:30 PM View: | Ra Capital Management, LLC Director | Point Biopharma Global Inc. (RACA) | 29-Jun-21 | Market Purchase | 209,100 | $10.00 | $2,091,000.00 | 24% 889.22K to 1.1M | < 1% |
| 30-Jun-21 4:31 PM View: | Kolchinsky Peter Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 29-Jun-21 | Grant | 209,100 | $10.00 | $2,091,000.00 | 24% 889.22K to 1.1M | < 1% |
| 24-Jun-21 7:08 PM View: | Kolchinsky Peter Chief Executive Officer Director | Point Biopharma Global Inc. (RACA) | 24-Jun-21 | Grant | 889,218 | $10.00 | $8,892,180.00 | 100% 0 to 889.22K |
